Papers › Mutual-Information Based Optimal Experimental Design for Hyperpolarized ¹³C-Pyruvate MRI
Mutual-Information Based Optimal Experimental Design for Hyperpolarized ¹³C-Pyruvate MRI
Prashant K. Jha, Christopher Walker, Drew Mitchell, J. Tinsley Oden, Dawid Schellingerhout, James A. Bankson, David T. Fuentes
The archive published only this paper's code-link row. Authors, date and abstract are from arXiv's metadata (CC0), read from the Kaggle arXiv metadata snapshot of 2026-09-12 where its title matched the archive's; the title is the archive's.
A key parameter of interest recovered from hyperpolarized (HP) MRI measurements is the apparent pyruvate-to-lactate exchange rate, k_(PL), for measuring tumor metabolism. This manuscript presents an information-theory-based optimal experimental design (OED) approach that minimizes the uncertainty in the rate parameter, k_(PL), recovered from HP-MRI measurements. Mutual information (MI) is employed to measure the information content of the HP measurements with respect to the first-order exchange kinetics of the pyruvate conversion to lactate. Flip angles of the pulse sequence acquisition are optimized with respect to the mutual information. Further, a spatially varying model (high-fidelity) based on the Block-Torrey equations is proposed and utilized as a control. A time-varying flip angle scheme leads to a higher parameter optimization that can further improve the quantitative value of mutual information over a constant flip angle scheme. However, the constant flip angle scheme leads to the best accuracy and precision when considering inference from noise-corrupted data. For the particular MRI data examined here, pyruvate and lactate flip angles of 35 and 28 degrees, respectively, were the best choice in terms of accuracy and precision of the parameter recovery. Moreover, the recovery of rate parameter k_(PL) from the data generated from the high-fidelity model highlights the influence of diffusion and strength of vascular source on the recovered rate parameter. Since the existing pharmacokinetic models for HP-MRI do not account for spatial variation, the optimized design parameters may not be fully optimal in a more general 3D setting.
Code
Repository list and official/mentioned flags are the archive's, frozen 2025-07-28. Reachability, where shown, is from one Syntology probe window (2026-09-16 to 2026-09-18); repositories not probed show nothing. GitHub stars are not tracked.
Code Syntology ran Syntology
Not run by Syntology. Nothing on this page verifies that the listed code works.
Results from the paper archive 2025-07-28
No leaderboard rows for this paper in the archive.
Report a problem or propose a change · a person checks every report against the paper or source before anything changes; decisions are listed on /corrections